People in the News

NEW YORK (GenomeWeb News) - James Mazzo has resigned as a member of Beckman Coulter’s board of directors. The company said in a filing with the US Securities and Exchange Commission that Mazzo’s resignation was related to Abbott Laboratories' acquisition of Advanced Medical Optics, where he is chief executive officer, president, and chairman, and it was not related to any disagreement with Beckman Coulter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.